CBDA Shows Promise in Protecting Brain from High-Fat Diet Damage

Preclinical research from Polish universities published in Inflammopharmacology reveals that CBDA (cannabidiolic acid), a non-decarboxylated cannabis component, significantly reduces neuroinflammation markers and prevents pathological lipid accumulation in the brain cortex. The study, conducted in rodents on high-fat diets, demonstrates that controlled CBDA administration restores insulin signaling in neurons, offering potential neuroprotective benefits. While these findings are physiologically significant, they remain preliminary and await validation in human clinical trials to determine therapeutic applications for diet-related neurological damage.